VRP-77353-16060
2 vaccinations
3 coded responses
13 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 543 / WI
- Registered
- 2021-01-05
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-05
Registered in v-safe
-
2021-01-05
Dose 1 — Pfizer-BioNTech
-
2021-01-06
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-01-07
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-01-08
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-10
- 2021-01-11
-
2021-01-26
Dose 2 — Pfizer-BioNTech
- 2021-01-26
-
2021-01-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
-
2021-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-01-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Good · Chills, Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-02-19
Survey response — day 21, dose 2MedDRA: Heavy menstrual bleeding, Menstruation delayed, Migraine — Feeling: FairFree text: Late menses and heavier bleeding, migraines that lasts daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-27
Survey response — 3 months, dose 2MedDRA: Fatigue, Feeling cold — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cold all the time and fatiguedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-27
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-02
-
2022-01-26
Survey response — 12 months, dose 2MedDRA: Chills, Cough, Oropharyngeal pain, Pain, Respiratory tract congestion, Rhinorrhoea, Throat irritation — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cough, congestion, runny nose, chills, aches, scratchy sore throatMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-05 | Pfizer-BioNTech | |
| 2 | 2021-01-26 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-27 | Unsuccessful |
Free text
Release 4 — day 21, dose 2
Symptoms: Late menses and heavier bleeding, migraines that lasts days
Release 8 — 3 months, dose 2
Symptoms: Cold all the time and fatigued
Release 11 — 12 months, dose 2
Symptoms: Cough, congestion, runny nose, chills, aches, scratchy sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Feeling cold | ✓ | ✓ | ✓ |
| SD | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SD | Menstruation delayed | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Throat irritation | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release